DENVER, CO, April 28 /CNW Telbec/ - Medical International Technology Inc.
(MDLH. PK) (http://www.mitcanada.ca http://www.mitinvest.ca), MIT is pleased
to announce that it has received a US$ 200,000 private placement from its
future Chinese partners. This private investment from our partners is an
important step towards the final stage of the negotiations and a commitment
towards MIT's technology and products.
This joint venture agreement will help Medical International Technologies
(MIT Canada) Inc. become a world leader in the Needle-Free technology and
reduce the world's dependence on needles. Moreover, it will ensure that MIT
injectors become an indispensable, environmentally friendly product for single
and mass vaccination, and biologics injectables for doctors and users around
the world. MIT's mission is to help make the world needle-free.
This technology is the outcome of more than twenty-eight years of
research and development and the driving force behind the Med-Jet(R) product
line for humans and the Agro-Jet(R) product line for animals.
Medical International Technology Inc. is pleased to continue providing a
safe and effective means to help prevent the spread of deadly diseases to both
humans and animals through the use of the Med-Jet(R) and Agro-Jet(R)
needle-free injection system.
Karim Menassa, President
On Behalf of the Board of Directors
About Medical International Technology, Inc. MIT CANADA, with offices in
Montreal, is a subsidiary of Denver, Colorado-based Medical International
Technology, Inc. (MIT USA), which specializes in the development, production,
marketing and sale of needle-free injectors both for humans and animals, for
individual and mass vaccinations.
The statements which are not historical facts contained in this press
release are forward-looking statements that involve certain risks and
uncertainties, including but not limited to risks associated with the
uncertainty of future financial results, additional financing requirements,
development and acquisition of new product lines and services, government
approval processes, the impact of competitive products or pricing a
technological changes, the effect of economic conditions and other
uncertainties, and the risk factors set forth from time to time in the
Company's SEC reports, including but not limited to its annual report on Form
10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K.
Medical International Technology Inc. takes no obligation to update or correct
For further information:
For further information: Karim Menassa, President, On Behalf of the
Board of Directors, (514) 339-9355, firstname.lastname@example.org